Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) has shared an update.
China Resources Pharmaceutical Group Ltd. has announced the composition of its board of directors, detailing the roles and committee memberships of each member. This announcement is significant as it outlines the leadership structure and governance framework, which are crucial for strategic decision-making and maintaining stakeholder confidence.
The most recent analyst rating on (HK:3320) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. is a Hong Kong-based company operating in the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products, serving a broad market with a range of healthcare solutions.
Average Trading Volume: 12,543,088
Technical Sentiment Signal: Buy
Current Market Cap: HK$33.55B
See more data about 3320 stock on TipRanks’ Stock Analysis page.